Autologous bone marrow-derived mesenchymal stem cells for interstitial fibrosis and tubular atrophy: a pilot study

BACKGROUND: Mesenchymal stem cells (MSCs)-based therapy has shown promising results for renal injury. In this study, the efficacy and safety of autologous bone marrow-derived mesenchymal stem cells (BM-MSCs) in treating nonspecific interstitial fibrosis and tubular atrophy (IFTA) were evaluated. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Lai, Xingqiang, Guo, Yuhe, Ma, Junjie, Fang, Jiali, Li, Guanghui, Xu, Lu, Yin, Wei, Chen, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425735/
https://www.ncbi.nlm.nih.gov/pubmed/34493167
http://dx.doi.org/10.1080/0886022X.2021.1968432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425735/
https://www.ncbi.nlm.nih.gov/pubmed/34493167
http://dx.doi.org/10.1080/0886022X.2021.1968432

Ejemplares similares